兩連板的威帝股份(603023.SH):威帝雲總線車聯網服務平台項目僅面向客車市場
格隆匯3月11日丨連續2個漲停的威帝股份(603023.SH)發佈公告稱,公司可轉換公司債券募投項目《威帝雲總線車聯網服務平台項目》僅面向客車市場,現處在軟件系統性能測試階段,公司存在建設計劃能否按時完成、技術進步、產業政策變化等風險。
公司在基本面無變化的情況下,近期股價波動巨大,自2020年2月25日以來,股價從4.66元/股,漲到6.27元/股,漲幅達34.55%,敬請投資者關注二級市場交易風險。
經公司自查並向控股股東、實際控制人書面發函查證,截止公告披露日,確認不存在應披露而未披露的重大事項或重要信息。
經公司自查,未發現應披露而未披露的重大風險事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.